CHI-ANS1 cardio-metabolic screening 

​

In order to combat the devastating diabetes pandemic, early diagnosis of the disease and prevention of its complications are essential. The ANS1 is a non-invasive device that can test sudomotor function, autonomic nerve system, and artery health, among other cardio-metabolic risk factors, thanks to its cutting-edge technology. In as little as seven minutes, it can identify diabetes, pre-diabetes, and diabetes complications.
 

​

​